About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Baltimore | 13,694 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,694 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2381-2400 of 13,694 trials

CompletedComparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site InfectionsPancreaticoduodenectomy is associated with high perioperative morbidity, with surgical site infection (SSIs) being one of the most common complications.NCT03021668·Baltimore, Maryland CompletedA Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionThis Phase 2 protocol is designed to compare two dose levels of Vapendavir versus placebo.NCT02367313·Birmingham, Alabama and 61 others

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

CompletedTrial to Assess Chelation Therapy (TACT)The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.NCT00044213·Little Rock, Arkansas and 85 others

CompletedStudy of KRN23 in Adults With X-linked Hypophosphatemia (XLH)The primary efficacy objective of this study is to establish the effect of burosumab treatment compared with placebo on increasing serum phosphorus levels in adults with XLH.NCT02526160·Los Angeles, California and 24 others

CompletedYouth Drug Abuse Family and Cognitive-Behavioral TherapyThis Stage II study is in response to NIDA's Behavioral Therapies Development Program (PA-99-107).NCT00198874·Baltimore, Maryland

RecruitingEffectiveness-Implementation Evaluation of Acute Kidney Injury Decision SupportStudy Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and…NCT06840210·Baltimore, Maryland

CompletedA Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple MyelomaThe purpose of this study is to evaluate the safety and preliminary efficacy of CC-95266 in participants with relapsed and/or refractory multiple myeloma (R/R MM).NCT04674813·Birmingham, Alabama and 9 others

Approved for marketingEAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA TxAdvanced Accelerator Applications is currently pursuing marketing approval for 177Lu-DOTA0-Tyr3-Octreotate (Lutathera).NCT02705313·Gilbert, Arizona and 40 others

TerminatedNilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)In this study, the efficacy and safety of nilotinib 400 mg twice daily, will be compared with imatinib 400 mg twice daily in patients with a suboptimal response to imatinib for…NCT00519090·Tucson, Arizona and 79 others

CompletedOptimal Platelet Dose Strategy for Management of ThrombocytopeniaThe primary objective of this study is to compare the three study arms of lower, medium, and higher dose platelet therapy with respect to the percentage of patients experiencing…NCT00128713·Atlanta, Georgia and 20 others

CompletedTreating Parents to Reduce NICU Transmission of Staphylococcus Aureus TrialThis trial will test the hypothesis that treating parents of neonates requiring NICU care with intranasal mupirocin and topical chlorhexidine bathing will reduce the spread of S…NCT02223520·Baltimore, Maryland and 1 other

CompletedPhase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral MonotherapyThis is an international, multicenter, randomized, double-blind, placebo-controlled, event driven study in subjects with pulmonary arterial hypertension.NCT01560624·Phoenix, Arizona and 154 others

CompletedA Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisTo compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.NCT00002068·San Francisco, California and 7 others

CompletedLenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasThis phase I/II trial studies the side effects and best dose of lenalidomide when given together with combination chemotherapy and to see how well they work in treating patients…NCT02213913·Chicago, Illinois and 5 others

CompletedPharmacokinetics and Pharmacodynamics of CHI-914 in Healthy ParticipantsThe purpose of the present study is to examine the pharmacokinetics and pharmacodynamics of cannabigerol (CBG; CHI-914), a naturally occurring chemical constituent of the cannabis…NCT05324982·Baltimore, Maryland

RecruitingA Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to evaluate the safety, and efficacy of zilovertamab vedotin (ZV) in…NCT05139017·Glendale, Arizona and 134 others

CompletedA Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)This Phase II study evaluated the safety and efficacy of LDE225 in adult and pediatric patients with Hh-pathway activated, relapsed MB.NCT01708174·Chicago, Illinois and 40 others

CompletedPerifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal CancerThe trial will compare the overall survival of perifosine plus capecitabine to placebo plus capecitabine in patients with refractory advanced colorectal cancer.NCT01097018·Alhambra, California and 64 others

TerminatedSafety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneThis study will evaluate the long-term safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM).NCT01089790·Birmingham, Alabama and 148 others

CompletedA Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerThe purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.NCT01306890·Bessemer, Alabama and 332 others

PreviousPage 120 of 685Next

Diabetes

in Baltimore

Heart Diseasein Baltimore